Skip to main content
Top

Gas exchange efficiency slopes to assess exercise tolerance in chronic obstructive pulmonary disease

Published in:

Abstract

Background

In patients with chronic obstructive pulmonary disease (COPD), the clinical use of the minute ventilation-carbon dioxide production (\(\rm{\dot V}\)E-\(\rm{\dot V}\)CO2) slope has been reported as a measure of exercise efficiency, but the oxygen uptake efficiency slope (OUES), i.e., the slope of oxygen uptake (\(\rm{\dot V}\)O2) versus the logarithmically transformed \(\rm{\dot V}\)E, has rarely been reported.

Methods

We hypothesized that the \(\rm{\dot V}\)E-\(\rm{\dot V}\)CO2 slope is more useful than OUES in clinical use for the pathophysiological evaluation of COPD. Then, we investigated the cardiopulmonary exercise testing parameters affecting each of these slopes in 122 patients with all Global Initiative for Chronic Obstructive Lung Disease (GOLD) COPD grades selected from our database.

Results

Compared with the GOLD I-II group (n = 51), peak \(\rm{\dot V}\)O2 (p < 0.0001), OUES (p = 0.0161), \(\rm{\dot V}\)E at peak exercise (p < 0.0001), and percutaneous oxygen saturation (SpO2) at peak exercise (p = 0.0004) were significantly lower in the GOLD III-IV group (n = 71). The GOLD III-IV group was divided into two groups by the exertional decrease in SpO2 from rest to peak exercise: 3% or less (the non-desaturation group: n = 23), or greater than 3% (the desaturation group: n = 48). OUES correlated only weakly with peak \(\rm{\dot V}\)O2, \(\rm{\dot V}\)E at peak exercise, and the difference between inspired and expired mean O2 concentrations (ΔFO2) at peak exercise, i.e., an indicator of oxygen consumption ability throughout the body, in the GOLD III-IV group with exertional hypoxemia. In contrast, the \(\rm{\dot V}\)E-\(\rm{\dot V}\)CO2 slope was significantly correlated with ΔFO2 at peak exercise, regardless of the COPD grade and exertional desaturation. Across all COPD stages, there was no correlation between the \(\rm{\dot V}\)E-\(\rm{\dot V}\)CO2 slope and \(\rm{\dot V}\)E at peak exercise, and stepwise analysis identified peak \(\rm{\dot V}\)O2 (p = 0.0345) and ΔFO2 (p < 0.0001) as variables with a greater effect on the \(\rm{\dot V}\)E-\(\rm{\dot V}\)CO2 slope.

Conclusions

The OUES may be less useful in advanced COPD with exertional hypoxemia. The \(\rm{\dot V}\)E-\(\rm{\dot V}\)CO2 slope, which is independent of \(\rm{\dot V}\)E, focuses on oxygen consumption ability and exercise tolerance in COPD, regardless of the exertional hypoxemia level and COPD grade. Therefore, the \(\rm{\dot V}\)E-\(\rm{\dot V}\)CO2 slope might be useful in establishing or evaluating tailor-made therapies for individual patient’s pathologies in COPD as an indicator focusing on oxygen consumption ability.
Title
Gas exchange efficiency slopes to assess exercise tolerance in chronic obstructive pulmonary disease
Authors
Hiromi Yanagi
Keisuke Miki
Kazumi Koyama
Satoshi Miyamoto
Yasuhiro Mihashi
Yuka Nagata
Kazuki Hashimoto
Hisako Hashimoto
Mari Fukai
Tomonori Maekura
Rika Yonezawa
Shizuka Sakaguchi
Takuro Nii
Takanori Matsuki
Kazuyuki Tsujino
Hiroshi Kida
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2024
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-024-03312-2
This content is only visible if you are logged in and have the appropriate permissions.
This content is only visible if you are logged in and have the appropriate permissions.

Keynote webinar | Spotlight on progress in colorectal cancer

  • Live
  • Webinar | 11-12-2025 | 18:00 (CET)

CRC remains a major global health burden, but advances in screening, treatment, and lifestyle-based prevention continue to reshape clinical practice. Gain insights into how the latest research can be leveraged to optimize patient care across the CRC continuum.

Watch it live: Thursday 11 December 2025, 18:00-19:30 (CET)

Prof. Antoni Castells
Prof. Edward Giovannucci
Join the webinar
Webinar

2025 ESMO Congress hub

Unlock your free and exclusive access to expert interviews, news, and more from the annual congress of the European Society for Medical Oncology.

Read more

Keynote webinar | Spotlight on functional neurological disorder

FND perplexes and frustrates patients and physicians alike. Limited knowledge and insufficient awareness delays diagnosis and treatment, and many patients feel misunderstood and stigmatized. How can you recognize FND and what are the treatment options?

Prof. Mark Edwards
Watch now
Video
Image Credits
Colon cancer illustration/© (M) KATERYNA KON/SCIENCE PHOTO LIBRARY / Getty Images, Cancer cell screening and treatment concept/© artacet / iStock / Getty Images Plus, Human brain illustration/© (M) CHRISTOPH BURGSTEDT / SCIENCE PHOTO LIBRARY / Getty Images